[Evaluation of the effect of subcutaneous heparin on blood coagulability and blood lipids in diabetic patients].
D001777:Blood Coagulation / Q000187:drug effects*; D001779:Blood Coagulation Factors; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005227:Fatty Acids / Q000097:blood; D006493:Heparin / Q000008:administration & dosage*; D006801:Humans; D007279:Injections, Subcutaneous; D008055:Lipids / Q000097:blood*; D014280:Triglycerides / Q000097:blood
D001779:Blood Coagulation Factors; D005227:Fatty Acids; D008055:Lipids; D014280:Triglycerides; D006493:Heparin
Appréciation de l'effet de l'héparine sous-cutanée sur la coagulabilité et les lipides sanguins chez les diabétiques.